10-month-old revived twice after being exposed to fentanyl

January 2, 2017

Authorities in Massachusetts say a 10-month-old baby had to be revived twice after she was exposed to fentanyl.

Police arrived at the Methuen (mih-THOO'-uhn) residence early Saturday afternoon after receiving a report of a not breathing.

First responders took the child to Lawrence General Hospital, where say she stopped breathing twice and had to be resuscitated. She was later airlifted to Tufts Medical Center in Boston, where she's in stable condition.

Authorities say hospital tests indicate the baby had the potent synthetic opioid fentanyl (FEHN'-tuh-nihl) in her system.

The Department of Children and Families says it has taken custody of the baby. The incident remains under investigation.

Mayor Stephen Zanni says, "The opioid epidemic knows no boundaries."

Explore further: 'Unprecedented' overdose epidemic from fentanyl in US

Related Stories

'Unprecedented' overdose epidemic from fentanyl in US

August 25, 2016
Painkillers containing illegally made fentanyl, a synthetic drug up to 100 times more potent than morphine, are responsible for a surge in overdose deaths in the United States, health authorities said Thursday.

Five things to know about America's synthetic-opioid epidemic

December 21, 2016
Government scientists say they're seeing the emergence of a new class of deadly drugs built to mimic the potent prescription painkiller fentanyl. What you need to know:

Canada opioid deaths reach new monthly high

December 19, 2016
Deaths from drug overdoses in November hit a new high in Canada's British Columbia province, epicenter of a raging national opioid crisis, health officials said on Monday.

Canada to ease drug consumption room rules as opioid deaths rise

December 12, 2016
Facing a growing opioid crisis, Canada's Liberal government on Monday removed hurdles to opening new drug-consumption rooms while expanding its fight against narcotics trafficking at the border.

Opioid abuse in Canada a 'national health emergency': minister

November 18, 2016
Deaths from opiate overdoses in Canada have become a "public health crisis" that could prompt the government to declare a national health emergency, the Canadian Health Minister said Friday.

Nose spray offers pain relief in childbirth

January 21, 2016
Pain relief during childbirth may soon be delivered via a self-administered nasal spray, thanks to research from University of South Australia midwifery researcher, Dr Julie Fleet.

Recommended for you

Fighting opioid addiction in primary care—new study shows it's possible

October 18, 2017
For many of the 2 million Americans addicted to opioids, getting good treatment and getting off prescription painkillers or heroin may seem like a far-off dream.

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.